Are you on a successful path to ending tuberculosis (TB)? This group of indicators will help you answer that question by providing standardized comparisons across the United States Agency for International Development’s (USAID’s) TB priority countries. These indicators are intended to help measure each outcome and impact; help decision-makers answer questions; and measure progress towards global and individual country targets.
PBMEF Indicators
Core Indicators
Extended Indicators
Active Case Finding (AF)
Contact Investigation (CI)
Drug-Resistant TB Notifications (RN)
[RN-2] DR-TB Case Detection
Drug-Resistant TB Treatment Success (RS)
Healthcare Worker Screening (HW)
Presumptive TB (PS)
Prevention (PV)
Private Sector (PR)
Sustainability (SN)
[SN-36] Effective NTP Capacity
[SN-41] Inclusiveness of Gender
[SN- 26A] JPR/JMM was Conducted Recently
[SN- 41C] C – TB Gender Assessment Report
[SN-12] Universal DST
[SN- 26B] Availability of Final JPR/JMM Report
[SN-14] Pediatric TB Treatment
[SN-28] Mandatory Notification
[SN-4] Domestic Funding for Drugs
[SN-18] TB Screening
[SN-32] TB Stigma Reduction
[SN-19] TBI TPT
[SN-33] Approval Process Efficiency
[SN-20] Regimen for TBI
[SN- 33A] Approval Process Efficiency – A
[SN- 33B] Approval Process Efficiency-B
[SN-8] Social Protection
[SN-35] NTP Capacity
TB Detection (DT)
[DT-1] TB Case Notifications 
TB Preventive Treatment (PT)
[PT-12] Percent of PLHIV Completed TPT
[PT-13] Percent TPT Patients LTFU
[PT-5] TPT – PLHIV Coverage 
TB Treatment Success (SS)
[SS-4] TB Treatment Outcome: LTFU
TB/HIV (TH)
[TH-28] PLHIV with TB Who Have CD4 > 100
[TH-29] PLHIV with TB Who Have CD4 > 350